Two months into taking Type II diabetes weight-loss drug Mounjaro, Elise Ramer, a PR pro in Sarasota, FL, started drinking protein shakes
Tirzepatide is a dual GIP/GLP-1 agonist with a different side effect profile
Spironolactone for Female Acne: A Meta-analysis of Safety and Efficacy
A 2025 review of research papers and patents by Jzwiak and colleagues examined the larger BPC-157 literature, reviewing preclinical data across cellular signaling, tissue biology, pharmacology, and other areas of scientific investigation
There will also be mild tightness or sensitivity can last for up to 2 weeks, but this is not severe
Academic researchers may be less familiar with FDA requirements for candidate biomarkers used in therapeutic decision making and may benefit from industry diagnostic partnerships, ideally early in the drug development process so that regulatory, legal, quality, and commercial considerations are factored into early clinical studies (Silva et al., 2018)
